Author details

Full Name

Varinderpal Kaur

Affiliation

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37148359	The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes.	Diabetologia	2023
37808749	Multi-ancestry Polygenic Mechanisms of Type 2 Diabetes Elucidate Disease Processes and Clinical Heterogeneity.	medRxiv	2023
37886436	Multi-ancestry Polygenic Mechanisms of Type 2 Diabetes Elucidate Disease Processes and Clinical Heterogeneity.	Res Sq	2023
37034649	Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications.	medRxiv	2023
35349657	Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682.	Diabetes Care	2022
35551307	Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation.	Nat Genet	2022
35864532	Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19.	Cardiovasc Diabetol	2022
35677078	Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19.	Res Sq	2022
35723666	Association of GLP1R Polymorphisms With the Incretin Response.	Journal of Clinical Endocrinology and Metabolism	2022
34862199	Recessive Genome-Wide Meta-analysis Illuminates Genetic Architecture of Type 2 Diabetes.	Diabetes	2022
34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Diabetes Care	2021
33106254	A Polygenic Score for Type 2 Diabetes Risk Is Associated With Both the Acute and Sustained Response to Sulfonylureas.		2021
29358691	Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes.	Nat Commun	2018
29326107	Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH).	Diabetes Care	2018
29849136	Publisher Correction: Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes.	Nat Commun	2018
25812009	The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.	PLoS One	2015
24148209	Composite endpoints in trials of type-2 diabetes.	Diabetes, Obesity and Metabolism	2014
17150967	Regulation of pancreas duodenum homeobox-1 expression by early growth response-1.	Journal of Biological Chemistry	2007
16543365	Regulation of insulin gene transcription by the immediate-early growth response gene Egr-1.	Endocrinology	2006
16099819	Overexpression of the coactivator bridge-1 results in insulin deficiency and diabetes.	Molecular Endocrinology	2006